Kugelmeiers AG

Kugelmeiers contributes to and provides accessibility to regenerative medicine, believing it to be a potential for future medical therapies that everyone should have access to. We developed as a result of 18 years of research and dedication in the
eld of transplant surgery, cell therapy and developmental biology, a technology and ecosystems allowing us to make an impact on islet, liver and many other cell therapies that rely on 3D spheroids that need a medical quality platform.